These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 1760410)
21. Desensitization and antagonism of rat polymorphonuclear leukocytes stimulated with PAF acether. Bureau M; Joseph D; Vargaftig BB Prostaglandins; 1987 Jan; 33(1):37-50. PubMed ID: 3035615 [TBL] [Abstract][Full Text] [Related]
22. Interaction of the Paf antagonist WEB 2086 and its hetrazepine analogues with human platelets and endothelial cells. Korth R; Hirafuji M; Keraly CL; Delautier D; Bidault J; Benveniste J Br J Pharmacol; 1989 Oct; 98(2):653-61. PubMed ID: 2555017 [TBL] [Abstract][Full Text] [Related]
23. Platelet-activating factor as an intercellular signal in neutrophil-dependent platelet activation. Zhou W; Javors MA; Olson MS J Immunol; 1992 Sep; 149(5):1763-9. PubMed ID: 1506691 [TBL] [Abstract][Full Text] [Related]
24. Influence of platelet activating factor antagonists on the protamine sulphate stimulated release of histamine from peritoneal mast cells of rats in vitro. Lohde C; Bahr T; Labes D; Grupe R Arzneimittelforschung; 1992 Jan; 42(1):27-31. PubMed ID: 1375025 [TBL] [Abstract][Full Text] [Related]
25. Production of platelet-activating factor by stimulated human polymorphonuclear leukocytes. Correlation of synthesis with release, functional events, and leukotriene B4 metabolism. Sisson JH; Prescott SM; McIntyre TM; Zimmerman GA J Immunol; 1987 Jun; 138(11):3918-26. PubMed ID: 3035016 [TBL] [Abstract][Full Text] [Related]
26. [Phospholipid thrombocyte activating factor, its analogs and antagonists: prospects of their use in medicine]. Kulikov VI; Muzia GI Vestn Akad Med Nauk SSSR; 1991; (10):13-7. PubMed ID: 1801455 [TBL] [Abstract][Full Text] [Related]
27. Effect of platelet-activating factor on porcine pulmonary blood vessels in vitro. Pritze S; Simmet T; Peskar BA Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct; 344(4):495-9. PubMed ID: 1766475 [TBL] [Abstract][Full Text] [Related]
28. IL-1-induced adhesion of polymorphonuclear leukocytes to cultured human endothelial cells. Role of platelet-activating factor. Breviario F; Bertocchi F; Dejana E; Bussolino F J Immunol; 1988 Nov; 141(10):3391-7. PubMed ID: 3263425 [TBL] [Abstract][Full Text] [Related]
29. Selective inhibition of adrenaline-induced human platelet aggregation by the structurally related Paf antagonist Ro 19-3704. Schattner M; Parini A; Fouque F; Vargaftig BB; Touqui L Br J Pharmacol; 1989 Apr; 96(4):759-66. PubMed ID: 2787179 [TBL] [Abstract][Full Text] [Related]
30. Neutrophils accentuate renal cold ischemia-reperfusion injury. Dose-dependent protective effect of a platelet-activating factor receptor antagonist. Riera M; Torras J; Herrero I; Valles J; Paubert-Braquet M; Cruzado JM; Alsina J; Grinyo JM J Pharmacol Exp Ther; 1997 Feb; 280(2):786-94. PubMed ID: 9023292 [TBL] [Abstract][Full Text] [Related]
31. Roles of prostacyclin, EDRF and active oxygens in leukocyte-dependent platelet adhesion to endothelial cells induced by platelet-activating factor in vitro. Hirafuji M; Shinoda H Br J Pharmacol; 1993 Jun; 109(2):524-9. PubMed ID: 8358552 [TBL] [Abstract][Full Text] [Related]
32. Separate induction of human blood platelet aggregation or cytotoxicity by different concentrations of PAF-acether and thrombin. Tran A; Vanhée D; Capron A; Vorng H; Braquet P; Joseph M Agents Actions; 1992 May; 36(1-2):39-43. PubMed ID: 1414687 [TBL] [Abstract][Full Text] [Related]
33. The role of platelet-activating factor (PAF) antagonists and nitric oxide in cardiac actions of PAF. Electrophysiological and morphological study. Kecskeméti V; Balogh I J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):723-35. PubMed ID: 11192945 [TBL] [Abstract][Full Text] [Related]
34. CV 6209 is a non-competitive antagonist of platelet-activating factor receptors on guinea-pig resident peritoneal macrophages. Stewart AG Clin Exp Pharmacol Physiol; 1989 Nov; 16(11):813-20. PubMed ID: 2558827 [TBL] [Abstract][Full Text] [Related]
35. Platelet-activating factor primes neutrophil responses to agonists: role in promoting neutrophil-mediated endothelial damage. Vercellotti GM; Yin HQ; Gustafson KS; Nelson RD; Jacob HS Blood; 1988 Apr; 71(4):1100-7. PubMed ID: 2451547 [TBL] [Abstract][Full Text] [Related]
36. Chemotactic effect of PAF-acether on peritoneal eosinophils from normal rats. Martins MA; Etienne A; Soulard C; Domingo MT; Braquet P Braz J Med Biol Res; 1989; 22(9):1151-4. PubMed ID: 2636011 [TBL] [Abstract][Full Text] [Related]
37. Enterolobin induces rat paw oedema independently of PAF-acether. Castro-Faria-Neto HC; Cordeiro RS; Martins MA; Correia-Da-Silva AC; Bozza PT; Sousa MV; Morhy L Mem Inst Oswaldo Cruz; 1991; 86 Suppl 2():129-31. PubMed ID: 1841984 [TBL] [Abstract][Full Text] [Related]
38. Effects of WEB 2086, an antagonist to the receptor for platelet-activating factor (PAF), on PAF-induced responses in the horse. Foster AP; Lees P; Andrews MJ; Cunningham FM Equine Vet J; 1992 May; 24(3):203-7. PubMed ID: 1318830 [TBL] [Abstract][Full Text] [Related]
39. Role of platelet-activating factor (PAF) in platelet accumulation in rabbit skin: effect of the novel long-acting PAF antagonist, UK-74,505. Pons F; Rossi AG; Norman KE; Williams TJ; Nourshargh S Br J Pharmacol; 1993 May; 109(1):234-42. PubMed ID: 8495241 [TBL] [Abstract][Full Text] [Related]